Stockscreener 앱 받기
0.403
3.33%
0.013
전일 마감가:
$0.39
열려 있는:
$0.39
하루 거래량:
693.81K
Relative Volume:
0.69
시가총액:
$10.70M
수익:
-
순이익/손실:
$-23.14M
주가수익비율:
-0.3978
EPS:
-1.0131
순현금흐름:
$-29.23M
1주 성능:
-18.42%
1개월 성능:
-29.17%
6개월 성능:
-29.91%
1년 성능:
-50.36%
1일 변동 폭
$0.385
$0.4069
1주일 범위
$0.385
$0.5052
52주 변동 폭
$0.34
$1.1609
BiomX Inc Stock (PHGE) Company Profile
명칭
BiomX Inc
전화
972 7 23942377
주소
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
PHGE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.403 | 10.36M | 0 | -23.14M | -29.23M | -1.0131 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-04-15 | 개시 | Ladenburg Thalmann | Buy |
BiomX Inc 주식(PHGE)의 최신 뉴스
Forecasting BiomX Inc. price range with options dataJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - newser.com
Why BiomX Inc. stock could be top winner2025 Sector Review & Growth Focused Stock Pick Reports - newser.com
How BiomX Inc. stock reacts to inflationary pressuresIPO Watch & Target Return Focused Stock Picks - newser.com
How BiomX Inc. stock compares with tech leadersPortfolio Performance Summary & Capital Protection Trading Alerts - newser.com
Why BiomX Inc. stock remains resilientWeekly Market Outlook & Smart Investment Allocation Tips - newser.com
Signal strength of BiomX Inc. stock in tech scannersTrade Signal Summary & Daily Chart Pattern Signal Reports - newser.com
What recovery options are there for BiomX Inc.July 2025 Review & Weekly High Potential Alerts - newser.com
Strategies to average down on BiomX Inc.July 2025 Analyst Calls & Community Verified Swing Trade Signals - newser.com
Will BiomX Inc. stock gain from green policiesJuly 2025 Final Week & Weekly Setup with High ROI Potential - newser.com
Using RSI to spot recovery in BiomX Inc.July 2025 Update & Verified Momentum Stock Watchlist - newser.com
Will BiomX Inc. stock split attract more investorsJuly 2025 Pullbacks & Accurate Entry/Exit Alerts - fcp.pa.gov.br
Predicting BiomX Inc. trend using moving averages2025 Pullback Review & Advanced Technical Analysis Signals - newser.com
Published on: 2025-11-06 02:03:08 - newser.com
BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025 - The Globe and Mail
Will BiomX Inc. stock draw ESG focused fundsJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
What Wall Street predicts for BiomX Inc. stock priceJuly 2025 Highlights & Capital Efficient Trading Techniques - fcp.pa.gov.br
BiomX (NYSE American: PHGE) schedules Nov. 12 third‑quarter call at 8:30 a.m. ET - Stock Titan
BiomX announces FDA feedback on development pathway for BX011 - MSN
Will BiomX Inc. stock rise with strong economyCPI Data & Free Community Supported Trade Ideas - newser.com
Is BiomX Inc. stock cheap at current valuationJuly 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Analyzing BiomX Inc. with multi timeframe chartsWeekly Trade Summary & Free AI Powered Buy and Sell Recommendations - newser.com
Full technical analysis of BiomX Inc. stockMarket Sentiment Summary & Daily Profit Focused Screening - newser.com
BiomX (PHGE) Gains FDA Support for BX011 in Diabetic Foot Infection Treatment - GuruFocus
BiomX Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections - The Manila Times
BiomX Inc. Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections - MarketScreener
Why BiomX Inc. stock remains stableBreakout Watch & Free Risk Controlled Daily Trade Plans - newser.com
BiomX Inc (PHGE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.44%
0.70%
자본화:
|
볼륨(24시간):